Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same author

Features predicting data exclusion in imaging studies of Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Blood-based proteomic signature of amyloidosis: identification of novel regulators of amyloid load.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

No cognitive or psychological impact from returning research Alzheimer disease biomarkers: A delayed-start, noninferiority, randomized clinical trial.

medRxiv : the preprint server for health sciences·2026
Same author

Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study.

Lancet (London, England)·2026

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Linda Karlsson1, Shorena Janelidze1, Nicolas R Barthélemy2

  • 1Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

将阿尔茨海默病 (AD) 液体生物标志物与参考蛋白质如Aβ40或非酸化 (np-tau) 进行正常化,显著改善了它们与大脑粉样蛋白和病理学的关联. 这提高了脑脊液 (CSF) 和血AD生物标志物的精度.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 生物标志物的发现和验证.
  • 神经退行性疾病诊断神经退行性疾病诊断
  • 阿尔茨海默病 (AD) 研究研究

背景情况:

  • 液体生物标志物对于阿尔茨海默病 (AD) 检测具有成本效益,但个体间的变化可能会影响准确性.
  • 之前的工作确定了参考蛋白质,改善了CSF Aβ42 / PET和CSF p-tau181 / PET之间的一致性.
  • 参考蛋白对CSFAD生物标志物与大脑病理学和血生物标志物改善相关性的影响尚不清楚.

研究的目的:

  • 为了研究参考蛋白对脑脊液 (CSF) AD生物标志物与大脑/粉样蛋白-β (Aβ) PET负载之间的关系的影响.
  • 为了确定血AD生物标志物是否可以通过结合参考蛋白来改善.
  • 评估使用CSF Aβ40或非化 (np-tau) 对生物标志物-病理学关联的正常化影响.

主要方法:

  • 使用瑞典BioFINDER-2队列 (n=1702) 进行分析.
  • 单独比较tau/Aβ-PET负载和CSF生物标志物 (例如,MTBR-tau243,p-tau异型,SNAP-25) 与使用单变量线性回归进行对参考蛋白 (Aβ40,np-tau) 的规范化之间的关联.
  • 将分析扩展到血生物标志物,并在骑士ADRC和TRIAD队列中验证了发现.

主要成果:

  • 脑脊髓细胞Aβ40的正常化显著加强了脑脊髓细胞生物标志物 (MTBR-tau243,p-tau异型,突触生物标志物) 和tau/Aβ-PET之间的关联.
  • 对CSF np-tau的规范化主要改善了CSF生物标志物和Aβ-PET之间的一致性.
  • 血生物标志物与tau/Aβ-PET的关联通过与血Aβ40或np-tau的正常化得到增强,研究结果在队列中复制.

结论:

  • 对参考蛋白 (Aβ40或np-tau) 的规范化增强了CSF和血AD生物标志物与大脑tau和Aβ病理学之间的关联.
  • 这种规范化策略提高了已建立的AD和突触液生物标志物的精度.
  • 参考蛋白正常化提高了阿尔茨海默病的液体生物标志物的准确性和可解释性.